The Impact of Emphysema in Pulmonary Fibrosis

Overview

Journal Eur Respir Rev

Specialty Pulmonary Medicine

Date 2013 Jun 4

PMID 23728869

Citations 53

Authors

Vincent Cottin

Affiliations

Soon will be listed here.

Abstract

Several groups have described a syndrome in which idiopathic pulmonary fibrosis (IPF) coexists with pulmonary emphysema. This comes as no surprise since both diseases are associated with a history of exposure to cigarette smoke. The syndrome of combined pulmonary fibrosis and emphysema (CPFE) is characterised by upper lobe emphysema and lower lobe fibrosis. Physiological testing of these patients reveals preserved lung volume indices contrasted by markedly impaired diffusion capacity. The incidence of CPFE remains unknown but several case series suggest that this subgroup may comprise up to 35% of patients with IPF. CPFE is a strong determinant of associated pulmonary hypertension (PH). In addition, CPFE has major effects on measures of physiological function, exercise capacity and prognosis, and may affect the results of pulmonary fibrosis trials. Further studies are needed to ascertain the aetiology, morbidity, mortality and management of the CPFE syndrome, with or without PH, and to evaluate novel therapeutic options in CPFE.

Citing Articles

Identifying health risk determinants and molecular targets in patients with idiopathic pulmonary fibrosis via combined differential and weighted gene co-expression analysis.

Moin A, Ullah M, Nipa J, Rahman M, Emran A, Islam M Front Genet. 2025; 15:1496462.

PMID: 39944354 PMC: 11813903. DOI: 10.3389/fgene.2024.1496462.

Research progress of SIRTs activator resveratrol and its derivatives in autoimmune diseases.

Yu X, Chen M, Wu J, Song R Front Immunol. 2024; 15:1390907.

PMID: 38962006 PMC: 11219927. DOI: 10.3389/fimmu.2024.1390907.

Impact of combined pulmonary fibrosis and emphysema on lung cancer risk and mortality in rheumatoid arthritis: A multicenter retrospective cohort study.

Mori S, Ueki Y, Hasegawa M, Nakamura K, Nakashima K, Hidaka T PLoS One. 2024; 19(2):e0298573.

PMID: 38412181 PMC: 10898759. DOI: 10.1371/journal.pone.0298573.

Transitional cell states sculpt tissue topology during lung regeneration.

Konkimalla A, Konishi S, Macadlo L, Kobayashi Y, Farino Z, Miyashita N Cell Stem Cell. 2023; 30(11):1486-1502.e9.

PMID: 37922879 PMC: 10762634. DOI: 10.1016/j.stem.2023.10.001.

The effect of CALIPER-derived parameters for idiopathic pulmonary fibrosis in predicting prognosis, progression, and mortality: a systematic review.

Jiao X, Song H, Liu W, Yang J, Wang Z, Yang D Eur Radiol. 2023; 33(10):7262-7273.

PMID: 37528299 DOI: 10.1007/s00330-023-10010-w.

References

Rogliani P, Mura M, Mattia P, Ferlosio A, Farinelli G, Mariotta S . HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema. Respir Med. 2008; 102(12):1753-61. DOI: 10.1016/j.rmed.2008.07.010. View

Savale L, Chaouat A, Bastuji-Garin S, Marcos E, Boyer L, Maitre B . Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009; 179(7):566-71. PMC: 4850213. DOI: 10.1164/rccm.200809-1398OC. View

Hiwatari N, Shimura S, Takishima T . Pulmonary emphysema followed by pulmonary fibrosis of undetermined cause. Respiration. 1993; 60(6):354-8. DOI: 10.1159/000196235. View

Valdes A, Andrew T, Gardner J, Kimura M, Oelsner E, Cherkas L . Obesity, cigarette smoking, and telomere length in women. Lancet. 2005; 366(9486):662-4. DOI: 10.1016/S0140-6736(05)66630-5. View

Galie N, Hoeper M, Humbert M, Torbicki A, Vachiery J, Barbera J . Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2009; 34(6):1219-63. DOI: 10.1183/09031936.00139009. View

Jankowich M, Polsky M, Klein M, Rounds S . Heterogeneity in combined pulmonary fibrosis and emphysema. Respiration. 2007; 75(4):411-7. DOI: 10.1159/000107048. View

Mura M, Zompatori M, Pacilli A, Fasano L, Schiavina M, Fabbri M . The presence of emphysema further impairs physiologic function in patients with idiopathic pulmonary fibrosis. Respir Care. 2006; 51(3):257-65. View

Mejia M, Carrillo G, Rojas-Serrano J, Estrada A, Suarez T, Alonso D . Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest. 2009; 136(1):10-15. DOI: 10.1378/chest.08-2306. View

Cottin V, Nunes H, Brillet P, Delaval P, Devouassoux G, Tillie-Leblond I . Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J. 2005; 26(4):586-93. DOI: 10.1183/09031936.05.00021005. View

10.

Hansell D . High-resolution computed tomography in the evaluation of fibrosing alveolitis. Clin Chest Med. 1999; 20(4):739-60, viii. DOI: 10.1016/s0272-5231(05)70253-7. View

11.

Brillet P, Cottin V, Letoumelin P, Landino F, Brauner M, Valeyre D . [Combined apical emphysema and basal fibrosis syndrome (emphysema/fibrosis syndrome): CT imaging features and pulmonary function tests]. J Radiol. 2009; 90(1 Pt 1):43-51. DOI: 10.1016/s0221-0363(09)70077-0. View

12.

Aduen J, Zisman D, Mobin S, Venegas C, Alvarez F, Biewend M . Retrospective study of pulmonary function tests in patients presenting with isolated reduction in single-breath diffusion capacity: implications for the diagnosis of combined obstructive and restrictive lung disease. Mayo Clin Proc. 2007; 82(1):48-54. DOI: 10.4065/82.1.48. View

13.

Cottin V, Reix P, Khouatra C, Thivolet-Bejui F, Feldmann D, Cordier J . Combined pulmonary fibrosis and emphysema syndrome associated with familial SFTPC mutation. Thorax. 2011; 66(10):918-9. DOI: 10.1136/thx.2010.151407. View

14.

Grubstein A, Bendayan D, Schactman I, Cohen M, Shitrit D, Kramer M . Concomitant upper-lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature. Respir Med. 2005; 99(8):948-54. DOI: 10.1016/j.rmed.2004.12.010. View

15.

Vehmas T, Kivisaari L, Huuskonen M, Jaakkola M . Effects of tobacco smoking on findings in chest computed tomography among asbestos-exposed workers. Eur Respir J. 2003; 21(5):866-71. DOI: 10.1183/09031936.03.00029002. View

16.

Marten K, Milne D, Antoniou K, Nicholson A, Tennant R, Hansel T . Non-specific interstitial pneumonia in cigarette smokers: a CT study. Eur Radiol. 2009; 19(7):1679-85. PMC: 2691530. DOI: 10.1007/s00330-009-1308-7. View

17.

Cottin V . Treatment of pulmonary hypertension in interstitial lung disease: do not throw out the baby with the bath water. Eur Respir J. 2013; 41(4):781-3. DOI: 10.1183/09031936.00024113. View

18.

Meltzer E, Noble P . Idiopathic pulmonary fibrosis. Orphanet J Rare Dis. 2008; 3:8. PMC: 2330030. DOI: 10.1186/1750-1172-3-8. View

19.

Usui K, Tanai C, Tanaka Y, Noda H, Ishihara T . The prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancer. Respirology. 2010; 16(2):326-31. DOI: 10.1111/j.1440-1843.2010.01907.x. View

20.

Hoyle G, Li J, Finkelstein J, Eisenberg T, Liu J, Lasky J . Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet-derived growth factor. Am J Pathol. 1999; 154(6):1763-75. PMC: 1866633. DOI: 10.1016/S0002-9440(10)65432-6. View